Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
Clinical trial NCT04087473 · COMPLETED
Trial details
- NCT number
- NCT04087473
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-23
- Primary completion
- 2025-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.